anonymous
Guest
anonymous
Guest
The expansion is a waste of money. PIP’s should be coming left and right. If not, a Consulting company should be brought in to access what’s wrong!
Do you really need a consulting company to tell you MANAGED CARE COVERAGE SUCKS ASS?!
This makes perfect sense. That way they cannot NDC block anymore. There is no way the customers won’t be able to access and prescribe the drug routinely on a daily basis moving forward. The RBM’s need to wake up and authorize the 9 dollar co pay program for cash pay ASAP.You want us to win? Give us a co-pay card that brings the co-pay to $9 for cash pay. That way you can bypass PA restrictions for commercial plans. If insurance is not as bad as upper management says then this will hardly impact the bottom dollar. Everyone wins.
This makes perfect sense. That way they cannot NDC block anymore. There is no way the customers won’t be able to access and prescribe the drug routinely on a daily basis moving forward. The RBM’s need to wake up and authorize the 9 dollar co pay program for cash pay ASAP.
Yes they do. All Regions have predetermined budgets so the RBD’s could easily authorize the, $9.00 for 3-month, co-pay program for cash pay. If I ever get promoted to RBM I would seriously consider implementing the program.RBM’s don’t have the authority or power to do that! What kind of people does Amarin hire?!!
Yes they do. All Regions have predetermined budgets so the RBD’s could easily authorize the, $9.00 for 3-month, co-pay program for cash pay. If I ever get promoted to RBM I would seriously consider implementing the program.
Devil’s Advocate here... if I’m UHC (or any other plan) why would I ever bother to put the drug on formulary; patients can get it for $9; no need to provide coverage. I get your point about building prescriber confidence in coverage, and it is valid. But the marketplace mechanics really does not make your idea viable.Sure we will lose money on the cash pay option but it will open up confidence in prescribing for all commercial patients and those are are easily covered will even out those losses we take where patients aren't covered.
Devil’s Advocate here... if I’m UHC (or any other plan) why would I ever bother to put the drug on formulary; patients can get it for $9; no need to provide coverage. I get your point about building prescriber confidence in coverage, and it is valid. But the marketplace mechanics really does not make your idea viable.
That's the catch 22 though isnt it? Some plans might choose to do this in that scenario. Or maybe we work with some sort of specialty pharmacy to control the prescriptions coming in house. Have this pharmacy take a more active role in the PA fulfillment process to keep our offices from that frustration. Prescriber confidence is important, and you're right. I'm afraid that there is no perfect way around this. It is just crazy to me that we have all these incredible benefits, medical societies buying into vascepa, a positive icer rating, etc. Yet managed care actually got worse across the board this year. We are growing despite these challenges but confidence among prescribers is waning.
Like it or not, this is why Big Pharma is needed to move a Game Changing Blockbuster like this. They have the resources to change things very quickly. I can only do so much here in my area with my hands handcuffed.